GBD. Causes of Death Collaborators (2024) Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2021;403:2100–32.
C O, R V, K K, et al. Coronary artery calcification: current concepts and clinical implications. Circulation 149. Epub ahead of print 16 January 2024. https://doi.org/10.1161/CIRCULATIONAHA.123.065657.
Généreux P, Madhavan MV, Mintz GS, et al. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS. J Am Coll Cardiol. 2014;63:1845–54.
Google Scholar
Bourantas CV, Zhang Y-J, Garg S, et al. Prognostic implications of coronary calcification in patients with obstructive coronary artery disease treated by percutaneous coronary intervention: a patient-level pooled analysis of 7 contemporary stent trials. Heart. 2014;100:1158–64.
Google Scholar
Echouffo-Tcheugui JB, Perreault L, Ji L, et al. Diagnosis and management of prediabetes: a review. JAMA. 2023;329:1206–16.
Google Scholar
Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
Google Scholar
Cai X, Zhang Y, Li M, et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. 2020;370:m2297.
Google Scholar
Kok MM, von Birgelen C, Sattar N, et al. Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population. EuroIntervention. 2018;14:e1049–56.
Google Scholar
Jin J-L, Cao Y-X, Zhang H-W, et al. Lipoprotein(a) and cardiovascular outcomes in patients with coronary artery disease and prediabetes or diabetes. Diabetes Care. 2019;42:1312–8.
Google Scholar
Ploumen EH, Pinxterhuis TH, Zocca P, et al. Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials. Cardiovasc Diabetol. 2021;20:217.
Google Scholar
Yuan D, Zhang C, Jia S, et al. Prediabetes and long-term outcomes in patients with three-vessel coronary artery disease: a large single-center cohort study. J Diabetes Investig. 2021;12:409–16.
Google Scholar
American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2021. Diabetes Care. 2021;44:S15–33.
Google Scholar
International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327–34.
Google Scholar
Choi IY, Chang Y, Cho Y, et al. Prediabetes diagnosis is associated with the progression of coronary artery calcification: the Kangbuk Samsung Health Study. Diabetes Obes Metab. 2022;24:2118–26.
Google Scholar
Cho Y, Chang Y, Ryu S, et al. Persistence or regression of prediabetes and coronary artery calcification among adults without diabetes. Eur J Endocrinol. 2023;188:001.
Google Scholar
Bonora E, Kiechl S, Willeit J, et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study. Diabetes Care. 2007;30:318–24.
Google Scholar
Kim SH, Reaven GM. Isolated impaired fasting glucose and peripheral insulin sensitivity: not a simple relationship. Diabetes Care. 2008;31:347–52.
Google Scholar
Ariel D, Reaven G. Modulation of coronary heart disease risk by insulin resistance in subjects with normal glucose tolerance or prediabetes. Acta Diabetol. 2014;51:1033–9.
Google Scholar
Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6:299–304.
Google Scholar
Gastaldelli A. Measuring and estimating insulin resistance in clinical and research settings. Obesity (Silver Spring). 2022;30:1549–63.
Google Scholar
Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95:3347–51.
Google Scholar
Zhang Q, Xiao S, Jiao X, et al. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001–2018. Cardiovasc Diabetol. 2023;22:279.
Google Scholar
Xiao E, Yu R, Cai X, et al. Development and validation of a novel metabolic health-related nomogram to improve predictive performance of cardiovascular disease risk in patients with prediabetes. Lipids Health Dis. 2025;24:45.
Google Scholar
Zhao S, Wang Z, Qing P, et al. Comprehensive analysis of the association between triglyceride-glucose index and coronary artery disease severity across different glucose metabolism states: a large-scale cross-sectional study from an Asian cohort. Cardiovasc Diabetol. 2024;23:251.
Google Scholar
Kim MK, Ahn CW, Kang S, et al. Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults. Cardiovasc Diabetol. 2017;16:108.
Google Scholar
Park K, Ahn CW, Lee SB, et al. Elevated TyG index predicts progression of coronary artery calcification. Diabetes Care. 2019;42:1569–73.
Google Scholar
Won K-B, Park EJ, Han D, et al. Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline. Cardiovasc Diabetol. 2020;19:34.
Google Scholar
Mintz GS, Popma JJ, Pichard AD, et al. Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. Circulation. 1995;91:1959–65.
Google Scholar
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.
Google Scholar
The Lancet Diabetes Endocrinology Null. Prediabetes: much more than just a risk factor. Lancet Diabetes Endocrinol. 2025;S2213–8587(25):00034–8.
Santulli G, Visco V, Ciccarelli M, et al. Frail hypertensive older adults with prediabetes and chronic kidney disease: insights on organ damage and cognitive performance—preliminary results from the CARYATID study. Cardiovasc Diabetol. 2024;23:125.
Google Scholar
Nigam A, Bourassa MG, Fortier A, et al. Fasting but not postprandial (postmeal) glycemia predicts the risk of death in subjects with coronary artery disease. Can J Cardiol. 2007;23:873–8.
Google Scholar
Song C, Yuan S, Cui K, et al. HbA1c-based rather than fasting plasma glucose-based definitions of prediabetes identifies high-risk patients with angiographic coronary intermediate lesions: a prospective cohort study. Cardiovasc Diabetol. 2023;22:68.
Google Scholar
Cederqvist J, Rådholm K, Nystrom FH, et al. Impaired microcirculation in the skin and subclinical atherosclerosis in individuals with dysglycaemia in a large population-based cohort. Cardiovasc Diabetol. 2025;24:86.
Google Scholar
Sheng Z, Zhou P, Liu C, et al. Relationships of coronary culprit-plaque characteristics with duration of diabetes mellitus in acute myocardial infarction: an intravascular optical coherence tomography study. Cardiovasc Diabetol. 2019;18:136.
Google Scholar
Marx N, Rydén L, Federici M, et al. Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction. Eur Heart J. 2024;45:5117–26.
Google Scholar
Liu H-H, Cao Y-X, Li S, et al. Impacts of prediabetes mellitus alone or plus hypertension on the coronary severity and cardiovascular outcomes. Hypertension. 2018;71:1039–46.
Google Scholar
Alizargar J, Bai C-H, Hsieh N-C, et al. Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients. Cardiovasc Diabetol. 2020;19:8.
Google Scholar
Sun Y, Ji H, Sun W, et al. Triglyceride glucose (TyG) index: a promising biomarker for diagnosis and treatment of different diseases. Eur J Intern Med. 2025;131:3–14.
Google Scholar
Gao X, Chen T, Zhou F, et al. The association between different insulin resistance surrogates and all-cause mortality and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2025;24:200.
Google Scholar
Sbriscia M, Colombaretti D, Giuliani A, et al. Triglyceride glucose index predicts long-term mortality and major adverse cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol. 2025;24:115.
Google Scholar
Gambardella J, Wang X, Mone P, et al. Genetics of adrenergic signaling drives coronary artery calcification. Atherosclerosis. 2020;310:88–90.
Google Scholar
Won K-B, Han D, Lee JH, et al. Evaluation of the impact of glycemic status on the progression of coronary artery calcification in asymptomatic individuals. Cardiovasc Diabetol. 2018;17:4.
Google Scholar
Liu F, Ling Q, Xie S, et al. Association between triglyceride glucose index and arterial stiffness and coronary artery calcification: a systematic review and exposure-effect meta-analysis. Cardiovasc Diabetol. 2023;22:111.
Google Scholar
Li L, Zhong H, Shao Y, et al. Association between the homeostasis model assessment of insulin resistance and coronary artery calcification: a meta-analysis of observational studies. Front Endocrinol (Lausanne). 2023;14:1271857.
Google Scholar
Santulli G, Visco V, Varzideh F, et al. Prediabetes increases the risk of frailty in prefrail older adults with hypertension: beneficial effects of metformin. Hypertension. 2024;81:1637–43.
Google Scholar
Liao J, Wang L, Duan L, et al. Association between estimated glucose disposal rate and cardiovascular diseases in patients with diabetes or prediabetes: a cross-sectional study. Cardiovasc Diabetol. 2025;24:13.
Google Scholar
Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10:293–302.
Google Scholar
Sasso FC, Pafundi PC, Caturano A, et al. Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes. Nutr Metab Cardiovasc Dis. 2021;31:2345–53.
Google Scholar